Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial to Evaluate MUltimodal Targeted Axillary Surgery (MUTAS) Approaches in Breast Cancer Patients With Positive Lymph Nodes.

NCT04039893 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT04039893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04039893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial to Evaluate MUltimodal Targeted Axillary Surgery (MUTAS) Approaches in Breast Cancer Patients With Positive Lymph Nodes.
Lead sponsor
Parc de Salut Mar
Phase
Not applicable
Overall status
Unknown status
Start date
October 23, 2019
Completion date
November 15, 2022
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

node-positive breast cancer